NET PROFIT (x1000 EUR)
EMPLOYEES
Wilson Therapeutics AB
Closing information (x1000 EUR)
| Closing information | 2020/12 | 2019/12 | 2018/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
87,768
|
217
|
328 |
| Earnings before taxes |
-67,516
|
645,902
|
-38,065 |
| EBITDA |
-83
|
638,155
|
-39,132 |
| Total assets |
641,755
|
1,247,207
|
7,857 |
| Current assets |
641,745
|
1,247,067
|
1,392 |
| Current liabilities |
6,681
|
571,290
|
4,346 |
| Equity capital |
635,074
|
675,918
|
3,498 |
| - share capital |
313
|
301
|
306 |
| Employees (average) |
0
|
1
|
14 |
Financial ratios
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Solvency |
99.0%
|
54.2%
|
44.5% |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
3.2%
|
51.8%
|
-480.3% |
| Current ratio |
9605.5%
|
218.3%
|
32.0% |
| Return on equity (ROE) |
-10.6%
|
95.6%
|
-1088.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
-13
|
0 |
| Chg. No. of employees % |
-100%
|
-93% |
Total value of public sale
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.